Download presentation
Presentation is loading. Please wait.
Published byGriselda Stevens Modified over 6 years ago
1
Treatment of Dyslipidemia in Allogeneic Hematopoietic Stem Cell Transplant Patients
Bernard Lawrence Marini, Sung Won Choi, Craig Alan Byersdorfer, Simon Cronin, David G. Frame Biology of Blood and Marrow Transplantation Volume 21, Issue 5, Pages (May 2015) DOI: /j.bbmt Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions
2
Biology of Blood and Marrow Transplantation 2015 21, 809-820DOI: (10
Biology of Blood and Marrow Transplantation , DOI: ( /j.bbmt ) Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions
3
Figure 1 Mechanism of statin immunomodulation in GVHD [17,55-58,60,61]. Treg indicates regulatory T cell; LFA1, leukocyte function-associated antigen-1; ICAM, intercellular adhesion molecule; CIIA, MHC class II transactivator; TCR, T cell receptor; MHCII, MHC complex class II; PP, pyrophosphate. Biology of Blood and Marrow Transplantation , DOI: ( /j.bbmt ) Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.